STOCK TITAN

Vanguard reports 0% stake in Diversified Healthcare Trust (DHC)

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed Amendment No. 2 on a Schedule 13G/A reporting its position in Diversified Healthcare Trust common stock. The filing states amount beneficially owned: 0 shares representing 0%. The filing explains an internal realignment on January 12, 2026 that led certain Vanguard subsidiaries and business divisions to report beneficial ownership separately. The disclosure is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports no beneficial ownership after internal disaggregation.

The Vanguard Group states it holds 0 shares of Diversified Healthcare Trust common stock, 0%, in this Amendment No. 2 filing. The form attributes the change to an internal realignment on January 12, 2026 under SEC Release No. 34-39538; certain subsidiaries now report separately.

These filings document reporting structure, not an economic transfer of securities. Cash‑flow treatment and trading activity are not disclosed in the provided excerpt; subsequent filings would show any holder-level transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does The Vanguard Group report in DHC?

The Vanguard Group reports owning 0 shares, representing 0%. The Schedule 13G/A Amendment No. 2 states the reported beneficial ownership is zero shares of Diversified Healthcare Trust common stock as filed on 03/26/2026.

Why did Vanguard change how it reports ownership in DHC?

Vanguard cites an internal realignment on January 12, 2026 The filing references SEC Release No. 34-39538 and explains certain subsidiaries/business divisions will report beneficial ownership separately from The Vanguard Group, Inc.

Does this filing indicate Vanguard sold DHC shares?

The filing does not state a sale or transaction. It records a beneficial ownership figure of 0 shares and explains a reporting disaggregation; no trading activity or proceeds are disclosed in the excerpt.

Who signed the Schedule 13G/A amendment for Vanguard?

Signed by Ashley Grim, Head of Global Fund Administration with the signature date shown as 03/26/2026. The signature appears at the end of the Amendment No. 2 filing excerpt.

Is Vanguard reporting any person with >5% ownership of DHC here?

No person is identified as having more than 5%. The filing states Vanguard and related managed accounts have rights to dividends/proceeds but that no other person's interest reported exceeds 5%.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026